Paper2168286
Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC and 7 others. Cancer Res, 1990. Cited by 344 papers, by iCite.
Cite this record
ConductScience Library. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Papers, record 2168286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2168286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenoma, Islet Cell | Major topic |
| Carcinoid Tumor | Major topic |
| Pancreatic Neoplasms | Major topic |
| Receptors, Neurotransmitter | Major topic |
| Biopsy, Needle | |
| Humans | |
| Octreotide | |
| Receptors, Somatostatin |
Source PubMed
Cited by88
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 344 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42918868 | Cancer theranostics. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/42918868 | PubMed |
| 42840449 | Gastroenteropancreatic Neuroendocrine Neoplasms: Clinical and Translational Perspectives. | JMA J | 2026 | https://conductscience.org/library/papers/42840449 | PubMed |
| 42524036 | Systemic therapy for gastroenteropancreatic neuroendocrine neoplasms: current landscape and future directions. | Ther Adv Med Oncol | 2026 | https://conductscience.org/library/papers/42524036 | PubMed |
| 41827131 | Medical Management of Well-Differentiated Pancreatic Neuroendocrine Tumors: From Conventional Therapies to Emerging Strategies. | J Clin Med | 2026 | https://conductscience.org/library/papers/41827131 | PubMed |
| 41150737 | In Silico Multitarget Profiling of Non-Selective Beta-Blockers Highlights Their Potential as Key Agents in Breast Cancer Adjuvant Therapy via ADRB2, ERBB2, and NPYR Receptors. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41150737 | PubMed |
| 41082053 | Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors. | Curr Treat Options Oncol | 2025 | https://conductscience.org/library/papers/41082053 | PubMed |
| 38777918 | [Clinical significance of neuroendocrine tumors : Incidence, symptoms, diagnosis, stage, and prognostic factors and their influence on disease management]. | Radiologie (Heidelb) | 2024 | https://conductscience.org/library/papers/38777918 | PubMed |
| 37190273 | Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190273 | PubMed |
| 37086273 | Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition. | Eur J Nucl Med Mol Imaging | 2023 | https://conductscience.org/library/papers/37086273 | PubMed |
| 36307533 | Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies. | Nat Rev Clin Oncol | 2023 | https://conductscience.org/library/papers/36307533 | PubMed |
| 36297443 | Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36297443 | PubMed |
| 35608703 | Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy. | Eur J Nucl Med Mol Imaging | 2022 | https://conductscience.org/library/papers/35608703 | PubMed |
| 35430346 | Double life: How GRK2 and β-arrestin signaling participate in diseases. | Cell Signal | 2022 | https://conductscience.org/library/papers/35430346 | PubMed |
| 35254612 | Neuroendocrine Tumors: a Relevant Clinical Update. | Curr Oncol Rep | 2022 | https://conductscience.org/library/papers/35254612 | PubMed |
| 35159027 | Treatment of Neuroendocrine Neoplasms with Radiolabeled Peptides-Where Are We Now. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35159027 | PubMed |
| 33950298 | In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease. | EJNMMI Res | 2021 | https://conductscience.org/library/papers/33950298 | PubMed |
| 33935979 | Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/33935979 | PubMed |
| 33452604 | The Landmark Series: Management of Small Bowel Neuroendocrine Tumors. | Ann Surg Oncol | 2021 | https://conductscience.org/library/papers/33452604 | PubMed |
| 33398457 | Clinical-Pathological Conference Series from the Medical University of Graz : Case No 173: A 77-year-old patient with adenocarcinoma of the prostate, liver metastases and watery diarrhea. | Wien Klin Wochenschr | 2021 | https://conductscience.org/library/papers/33398457 | PubMed |
| 33391488 | Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response. | Theranostics | 2021 | https://conductscience.org/library/papers/33391488 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SST | 6750 | PubTator's text mining | https://conductscience.org/library/genes/6750 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2168286
GET https://conductscience.org/api/papers/v1/2168286/cited_by?page=2